Sarcopenia and Cachexia

[1]  J. Morley,et al.  Cachexia: pathophysiology and clinical relevance. , 2006, The American journal of clinical nutrition.

[2]  I. Janssen.  Influence of Sarcopenia on the Development of Physical Disability: The Cardiovascular Health Study , 2006, Journal of the American Geriatrics Society.

[3]  Shalender Bhasin,et al.  Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. , 2005, The Journal of clinical endocrinology and metabolism.

[4]  R. Baumgartner,et al.  Cytokine-related aging process. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  C. Cooper,et al.  Does sarcopenia originate in early life? Findings from the Hertfordshire cohort study. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[6]  E. McNally.  Powerful genes--myostatin regulation of human muscle mass. , 2004, The New England journal of medicine.

[7]  R. Ross,et al.  Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. , 2004, American journal of epidemiology.

[8]  Marjolein Visser,et al.  Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. , 2003, The Journal of clinical endocrinology and metabolism.

[9]  J. Hopper,et al.  Serum Vitamin D and Falls in Older Women in Residential Care in Australia , 2003, Journal of the American Geriatrics Society.

[10]  I. Reid,et al.  Effects of Vitamin D Supplementation on Strength, Physical Performance, and Falls in Older Persons: A Systematic Review , 2003, Journal of the American Geriatrics Society.

[11]  J. Morley.  Hormones and the Aging Process , 2003, Journal of the American Geriatrics Society.

[12]  Matthew T. Haren,et al.  Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[13]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[14]  E. Baulieu,et al.  Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. , 2003, Archives of internal medicine.

[15]  K. Chad,et al.  Creatine supplementation combined with resistance training in older men. , 2001, Medicine and science in sports and exercise.

[16]  N. Dombros.  Pathogenesis and management of malnutrition in chronic peritoneal dialysis patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  Ronenn Roubenoff,et al.  From the Chicago MeetingsSarcopenia , 2001 .

[18]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[19]  R. Baumgartner,et al.  Longitudinal changes in serum 25-hydroxyvitamin D in older people. , 1999, Metabolism: clinical and experimental.

[20]  R. Baumgartner,et al.  Predictors of skeletal muscle mass in elderly men and women , 1999, Mechanisms of Ageing and Development.

[21]  H. Perry,et al.  Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. , 1997, The Journal of clinical endocrinology and metabolism.

[22]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[23]  P J Garry,et al.  Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. , 1997, Metabolism: clinical and experimental.

[24]  S. Maggi,et al.  Relation between vitamin D, physical performance, and disability in elderly persons. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[25]  G. Cancarini,et al.  Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.